Annual Lung SPORE Workshop (Abstract Submission)

76 submissions
Created First Name Last Name Email Phone Select a Session Topic Abstract Title First Author First Name First Author Last Name Affiliation List of Additional Authors Your Abstract Submission Upload Abstract Special Characters Included? Abstract Review Status Upload Poster Poster Uploaded Operations
Mon, 03/11/2024 - 10:17 Kersten Pierre kpier26@emory.edu 8324019591 Session 2: Health Disparities in Lung Cancer, Session 3: Immuno-oncology Communication Issues in Patient/Provider Discussions of Immunotherapy Kersten Pierre Winship Cancer Institute at Emory University
  • First Name: Ayannah
    Last Name: Lang
    Affiliation: Winship Cancer Institute at Emory University
  • First Name: Rebecca
    Last Name: Pentz, PhD
    Affiliation: Winship Cancer Institute at Emory University
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 09:40 Francisco Exposito francisco.exposito@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Investigating Lkb1 loss as novel synthetic vulnerability in EGFR-driven lung cancer Francisco Exposito Yale Cancer Center, New Haven; Yale School of Medicine, New Haven, USA
  • First Name: Emily
    Last Name: Shuldiner
    Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA
  • First Name: Steven
    Last Name: Lopez
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Minwei
    Last Name: Wang
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Mariana
    Last Name: Do Carmo
    Affiliation: Department of Pathology, Yale School of Medicine, New Haven, CT, USA
  • First Name: Laura
    Last Name: Andrejka
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Giorgia
    Last Name: Foggetti
    Affiliation: Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • First Name: Christopher
    Last Name: W. Murray
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Dimitri
    Last Name: Petrov
    Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA
  • First Name: Monte
    Last Name: Winslow
    Affiliation: Division of Oncology, Department of Medicine / Stanford Cancer Institute / Department of Pathology, Stanford University School of Medicine, Stanford, California
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Department of Pathology, Yale School of Medicine / Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 09:20 Andrey Ivanov andrey.ivanov@emory.edu (404) 727-6343 Session 6: Cancer Biology The AVERON Notebook: a computational approach to druggable cancer dependencies enabled by mutant-directed protein-protein interactions. Hongyue (Nicole) Chen Emory University
  • First Name: Brian
    Last Name: Revennaugh
    Affiliation: Emory University
  • First Name: Haian
    Last Name: Fu
    Affiliation: Emory University
  • First Name: Andrey
    Last Name: Ivanov
    Affiliation: Emory University
Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 09:03 Rebecca Starble rebecca.starble@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Epigenetic priming promotes acquisition of tyrosine kinase inhibitor resistance and oncogene amplification in human lung cancer Rebecca Starble Yale University
  • First Name: Eric
    Last Name: Sun
    Affiliation: Yale University
  • First Name: Rana
    Last Name: Gbyli
    Affiliation: Yale University
  • First Name: Jonathan
    Last Name: Radda
    Affiliation: Yale University
  • First Name: Jiuwei
    Last Name: Lu
    Affiliation: University of California, Riverside
  • First Name: Tyler
    Last Name: Jensen
    Affiliation: Yale University
  • First Name: Ning
    Last Name: Sun
    Affiliation: Yale University
  • First Name: Nelli
    Last Name: Khudaverdyan
    Affiliation: University of California, Riverside
  • First Name: Bomiao
    Last Name: Hu
    Affiliation: Yale University
  • First Name: Mary Ann
    Last Name: Melnick
    Affiliation: Yale University
  • First Name: Shuai
    Last Name: Zhao
    Affiliation: Duke University School of Medicine
  • First Name: Nitin
    Last Name: Roper
    Affiliation: National Cancer Institute
  • First Name: Greg
    Last Name: Wang
    Affiliation: Duke University School of Medicine
  • First Name: Jikui
    Last Name: Song
    Affiliation: University of California, Riverside
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Yale University
  • First Name: Siyuan
    Last Name: Wang
    Affiliation: Yale University
  • First Name: Andrew
    Last Name: Xiao
    Affiliation: Yale University
Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 08:39 Jordan Cardenas jordan.cardenas@yale.edu 3039196514 Session 3: Immuno-oncology The combination of modified IL-18 with anti-PD1 elicits a CD4+ T cell-mediated antitumor response in MHC Class I-deficient models of non-small cell lung cancer Jordan Cardenas Yale
  • First Name: Camila
    Last Name: Robles-Oteiza
    Affiliation: Yale
  • First Name: Ting
    Last Name: Zhou
    Affiliation: Yale
  • First Name: John
    Last Name: Huck
    Affiliation: Yale
  • First Name: Paula
    Last Name: Kavathas
    Affiliation: Yale
  • First Name: Aaron
    Last Name: Ring
    Affiliation: Fred Hutch
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Yale
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 06:48 Elliott Brea elliott_brea@dfci.harvard.edu 8479221042 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Development and effectiveness of TROP2 CAR T in EGFRm NSCLC including in TROP2 ADC refractory settings Elliott Brea DFCI
  • First Name: Eric
    Last Name: Smith
    Affiliation: DFCI
  • First Name: David
    Last Name: Barbie
    Affiliation: DFCI
  • First Name: Sachiv
    Last Name: Chakravarti
    Affiliation: DFCI
  • First Name: Alexis
    Last Name: Mottram
    Affiliation: DFCI
  • First Name: Prafulla
    Last Name: Gokhale
    Affiliation: DFCI
  • First Name: Ken
    Last Name: Ng
    Affiliation: DFCI
  • First Name: Cloud
    Last Name: Paweletz
    Affiliation: DFCI
  • First Name: Pasi
    Last Name: Jänne
    Affiliation: DFCI
  • First Name: Simon
    Last Name: Baldacci
    Affiliation: DFCI
  • First Name: Elena
    Last Name: Ivanova
    Affiliation: DFCI
  • First Name: Ha
    Last Name: Vo
    Affiliation: DFCI
  • First Name: Tran
    Last Name: Thai
    Affiliation: DFCI
  • First Name: Timothy
    Last Name: Haggerty
    Affiliation: DFCI
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 03:50 James Kim James.Kim@UTSouthwestern.edu 214-648-4180 Session 4: Small Cell Lung Cancer A Model of Human Small Cell Lung Cancer Metastasis Utilizing Orthotopic Transplantation of Patient-Derived Xenografts Shreoshi Pal Choudhuri University of Texas Southwestern
  • First Name: Kyle
    Last Name: May
    Affiliation: University of Texas Southwestern
  • First Name: Thomas
    Last Name: Salisbury
    Affiliation: University of Texas Southwestern
  • First Name: Chamey
    Last Name: Suchors
    Affiliation: University of Texas Southwestern
  • First Name: Braeden
    Last Name: Freitas
    Affiliation: University of Texas Southwestern
  • First Name: Seth
    Last Name: Hamilton
    Affiliation: University of Texas Southwestern
  • First Name: Victor
    Last Name: Chien
    Affiliation: University of Texas Southwestern
  • First Name: Benjamin
    Last Name: Drapkin
    Affiliation: University of Texas Southwestern
  • First Name: James
    Last Name: Kim
    Affiliation: University of Texas Southwestern
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 00:35 Jianfeng Li jianfeng.li@emory.edu (412) 973-4647 Session 3: Immuno-oncology Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancer Changfa Shu Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Jianfeng
    Last Name: Li
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Rui
    Last Name: Jin
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Dacheng
    Last Name: Fan
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Qiankun
    Last Name: Niu
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Danielle
    Last Name: Cicka
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Sean
    Last Name: Doyle
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Alafate
    Last Name: Wahafu
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Xi
    Last Name: Zheng
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Yuhong
    Last Name: Du
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Andrey A.
    Last Name: Ivanov
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Deon B
    Last Name: Doxie
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Kavita M
    Last Name: Dhodapkar
    Affiliation: Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA
  • First Name: Jennifer
    Last Name: Carlisle
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Taofeek
    Last Name: Owonikoko
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Gabriel
    Last Name: Sica
    Affiliation: Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA
  • First Name: Yuan
    Last Name: Liu
    Affiliation: Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA
  • First Name: Suresh
    Last Name: Ramalingam
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Madhav V
    Last Name: Dhodapkar
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Wei
    Last Name: Zhou
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Xiulei
    Last Name: Mo
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Haian
    Last Name: Fu
Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 00:05 Kevin Levine klevine2@fredhutch.org Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Continued EGFR Dependency in a Patient with Lung Cancer Harboring an EGFR Kinase Domain Duplication Kevin Levine Fred Hutch Cancer Center
  • First Name: Alice
    Last Name: Berger
    Affiliation: Fred Hutch Cancer Center
  • First Name: Colin
    Last Name: Pritchard
    Affiliation: University of Washington
  • First Name: Christina
    Last Name: Baik
    Affiliation: Fred Hutch Cancer Center
Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 23:49 Ling Cai ling.cai.30@gmail.com 2146975362 Session 6: Cancer Biology A Lung Cancer Mouse Model Database Ling Cai Quantitative Biomedical Research Center, School of Public Health, University of Texas Southwestern Medical Center Abstract_Submission.pdf
Cai_UTSW_6.docx15.39 KB
No Approved to be a Poster Presenter
Sun, 03/10/2024 - 21:37 Tang Tang tang.tang@yale.edu 5307509166 Session 3: Immuno-oncology Modeling immune evasion and immunotherapy response in distant metastases of lung adenocarcinoma Tang Tang Yale School of Medicine
  • First Name: Kelli
    Last Name: Conolly
    Affiliation: Yale School of Medicine
  • First Name: Nikhil
    Last Name: Joshi
    Affiliation: Yale School of Medicine
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale School of Medicine
Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:59 Stefan Harry sharry@mgh.harvard.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Systematic Targeting of Protein Complexes with Staples Stefan Harry Harvard University and MGH
  • First Name: Diane
    Last Name: Yang
    Affiliation: MGH
  • First Name: Liron
    Last Name: Bar-Peled
    Affiliation: MGH
  • First Name: John
    Last Name: Iafrate
    Affiliation: MGH
  • First Name: Brian
    Last Name: Liau
    Affiliation: Harvard University
Abstract_Submission.pdf
abstract.docx13.34 KB
No Approved to be a Speaker
Sun, 03/10/2024 - 20:52 Matthew Wang matthew.wang.mcw69@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Understanding the role of alternative RNA splicing in Osimertinib resistance in lung adenocarcinoma Matthew Wang Department of Molecular Biophysics and Biochemistry, Yale University, USA
  • First Name: Robert
    Last Name: Tesng
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Li-Ting
    Last Name: Ku
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Xinning
    Last Name: Shan
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Joanne
    Last Name: Chen
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Department of Pathology, Yale University, USA
  • First Name: Luisa
    Last Name: Escobar-Hoyos
    Affiliation: Department of Molecular Biophysics and Biochemistry, Yale University, USA; Department of Therapeutic Radiology, Yale University, USA
Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:25 Diane Yang dyang17@mgh.harvard.edu Session 6: Cancer Biology Profiling the protein interactome through cysteine-reactive libraries has revealed the identification of EML4ALK dimerizers Diane Yang Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Stefan
    Last Name: Harry
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Elizabeth
    Last Name: Codd
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Stefan
    Last Name: Kaluziak
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Edwin
    Last Name: Zhang
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Alexander Daniel
    Last Name: Carlin
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Zavontae
    Last Name: Oppong-Holmes
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Wendy
    Last Name: Yang
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Abigail
    Last Name: Smith
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Dawn
    Last Name: Mitchell
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Mariko
    Last Name: Hara
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Siwen
    Last Name: Zhang
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Harrison Byron
    Last Name: Chong
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Maristela
    Last Name: Onozato
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Liron
    Last Name: Bar-Peled
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: A. John
    Last Name: Iafrate
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:25 Alice Berger ahberger@fredhutch.org 2066676281 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Systematic discovery of osimertinib resistance variants using CRISPR prime editing Alice Berger Fred Hutch Abstract_Submission.pdf No Approved to be a Speaker
Sun, 03/10/2024 - 20:03 Caro Kravitz caro.kravitz@yale.edu Session 6: Cancer Biology The lysine demethylase KDM2A regulates tumor cell clustering to potentiate metastasis Caro Kravitz Yale University
  • First Name: Kiran
    Last Name: Patel
    Affiliation: Yale
  • First Name: Wesley
    Last Name: Cai
    Affiliation: Yale
  • First Name: Anna
    Last Name: Arnal-Estapé
    Affiliation: Yale
  • First Name: Dejian
    Last Name: Zhao
    Affiliation: Yale
  • First Name: Emily
    Last Name: Wingrove
    Affiliation: Yale
  • First Name: Laura
    Last Name: Stevens
    Affiliation: Yale
  • First Name: Thomas
    Last Name: Westbrook
    Affiliation: Baylor
  • First Name: Qin
    Last Name: Yan
    Affiliation: Yale
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Yale
Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 17:40 Jia Luo jia_luo@dfci.harvard.edu 6176323000 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Clinicopathologic and genomic features of patients with mucinous lung adenocarcinoma and response to systemic therapies Alessandro Di Federico DFCI
  • First Name: Lingzhi
    Last Name: Hong
    Affiliation: MDACC
  • First Name: Arielle
    Last Name: Elkrief
    Affiliation: MSKCC
  • First Name: Rohit
    Last Name: Thummalapalli
    Affiliation: MSKCC
  • First Name: Biagio
    Last Name: Ricciuti
    Affiliation: DFCI
  • First Name: Joao
    Last Name: Alessi
    Affiliation: DFCI
  • First Name: Pooja
    Last Name: Gogia
    Affiliation: MSKCC
  • First Name: Federica
    Last Name: Pecci
    Affiliation: DFCI
  • First Name: Malini
    Last Name: Gandhi
    Affiliation: DFCI
  • First Name: Marc
    Last Name: Ladanyi
    Affiliation: MSKCC
  • First Name: Jianjun
    Last Name: Zhang
    Affiliation: MDACC
  • First Name: Don
    Last Name: Gibbons
    Affiliation: MDACC
  • First Name: John
    Last Name: Heymach
    Affiliation: MDACC
  • First Name: Mizuki
    Last Name: Nishino
    Affiliation: DFCI
  • First Name: Lynette
    Last Name: Sholl
    Affiliation: BWH
  • First Name: Mark
    Last Name: Awad
    Affiliation: DFCI
  • First Name: Kathryn
    Last Name: Arbour
    Affiliation: MSKCC
  • First Name: Adam
    Last Name: Schoenfeld
    Affiliation: MSKCC
  • First Name: Natalie
    Last Name: Vokes
    Affiliation: MDACC
  • First Name: Jia
    Last Name: Luo
    Affiliation: DFCI
Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 16:59 Triparna Sen triparna.sen@mssm.edu 9179723836 Session 3: Immuno-oncology ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes anti-tumor immunity in SCLC. Triparna Sen Icahn School of Medicine at Mount Sinai Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 16:56 Siyuan Wang siyuan.wang@yale.edu 2037854511 Session 6: Cancer Biology A genome-wide single-cell 3D genome atlas of lung cancer progression Miao Liu Yale University Department of Genetics
  • First Name: Shengyan
    Last Name: Jin
    Affiliation: Yale University Department of Genetics
  • First Name: Sherry
    Last Name: Agabiti
    Affiliation: Yale University Department of Genetics
  • First Name: Tyler
    Last Name: Jensen
    Affiliation: Yale University Department of Genetics
  • First Name: Tianqi
    Last Name: Yang
    Affiliation: Yale University Department of Genetics
  • First Name: Jonathan
    Last Name: Radda
    Affiliation: Yale University Department of Genetics
  • First Name: Christian
    Last Name: Ruiz
    Affiliation: Yale University Department of Genetics
  • First Name: Gabriel
    Last Name: Baldissera
    Affiliation: Yale University Department of Genetics
  • First Name: Mandar
    Last Name: Muzumdar
    Affiliation: Yale University Department of Genetics, Department of Internal Medicine, Yale Cancer Biology Institute, Yale Cancer Center
Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 16:02 Triparna Sen triparna.sen@mssm.edu 9179723836 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Multi-omic characterization of KRAS/STK11/KEAP1 co-mutant non-small cell lung cancer (NSCLC) displays a unique metabolic profile and therapeutic vulnerabilities. Triparna Sen Icahn School of Medicine at Mount Sinai Abstract_Submission.pdf No Approved to be a Speaker